Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review.

Vender, Ronald; Turchin, Irina; Lansang, Perla; Prajapati, Vimal H; Legault, Mark; Barakat, Maxime; Yeung, Jensen

Vender, Ronald; Turchin, Irina; Lansang, Perla; Prajapati, Vimal H; Legault, Mark; Barakat, Maxime; Yeung, Jensen.

Afiliação

Vender R; Department of Medicine, Division of Dermatology, McMaster University, Hamilton, Ontario, Canada.
Turchin I; Dermatrials Research Inc, Hamilton, Ontario, Canada.
Lansang P; Brunswick Dermatology Centre, Fredericton, New Brunswick, Canada.
Prajapati VH; Dalhousie University, Halifax, Nova Scotia, Canada.
Legault M; Probity Medical Research, Waterloo, Ontario, Canada.
Barakat M; Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada.
Yeung J; Division of Dermatology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

JAAD Int ; 8: 60-63, 2022 Sep.

Article em En | MEDLINE | ID: mdl-35721301

Palavras-chave

biologic; corticosteroid; fixed combination; plaque psoriasis; real-world; retinoid; retrospective chart review; topical

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JAAD Int Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google